1. Brown TT, Cole SR, Li X, et al. Antiretroviral therapy and the prevalenceand incidence of diabetes mellitus in the Multicenter AIDS Cohort Study. Arch Intern Med. 2005; 165(10): 1179-1184. doi: 10.1001/archinte.165.10.1179
2. Capeau J, Bouteloup V, Katlama C, et al. Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. AIDS. 2012; 26: 303-314. doi: 10.1097/QAD.0b013e32834e8776
3. Jin C, Ji S, Xie t, et al. Severe dyslipidemia and immune activation in HIV patients with dysglycemia. HIV Clin Trials. 2016; 13: 1-8. doi: 10.1080/15284336.2016.1207297
4. Sobieszczyk ME, Werner L, Mlisana K, et al. Metabolic syndrome after HIV acquisition in South African women. J Acquir Immune Defic Syndr. 2016. doi: 10.1097/QAI.0000000000001123
5. Dimala CA, Atashili J, Mbuagbaw JC, Wilfred A, Monekosso GL. A comparison of the diabetes risk score in HIV/AIDS patients on highly active antiretroviral therapy (HAART) and HAART-naïve patients at the Limbe regional hospital, Cameroon. PLoS One. 2016; 11(5): e0155560. doi: 10.1371/journal.pone.0155560
6. Moreira RC, Pacheco AG, Paula A, et al. Diabetes mellitus is associated with increased death rates among HIV-infected patients in Rio de Janeiro, Brazil. AIDS Res Hum Retroviruses. 2016. doi: 10.1089/aid.2015.0265
7. Brar I, Shuter J, Thomas A, et al. A comparison of factors associated with prevalent diabetes mellitus among HIV-infected antiretroviral-naive individuals versus individuals in the national health and nutritional examination survey cohort. J Acquir Immune Defic Syndr. 2007; 45(1): 66-71. doi: 10.1097/QAI.0b013e318031d7e3
8. Noor MA, Lo JC, Mulligan K, et al. Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS. 2001; 15(7): F11- F18. Website. http://journals.lww.com/aidsonline/pages/articleviewer.aspx?year=2001&issue=05040&article=00001&type=abstract. Accessed August 5, 2016
9. Fuchsburger C, Flannick J, Teslovich TM, et al. The genetic architecture of type 2 diabetes. Nature. 2016; 536(7614): 41-47. doi: 10.1038/nature18642
10. Gaulton KJ, Ferreira T, Lee Y, et al. Genetic fine-mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci. Nat Genet. 2015; 47: 1415-1425. doi: 10.1038/ng.3437
11. Voight BF, Scott LJ, Steinthorsdottir V, et al. Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet. 2010; 42: 579-589. doi: 10.1038/ng.609
12. Locke AE, Kahali B, Berndt SI, et al. Genetic studies of body mass index yield new insights for obesity biology. Nature. 2015; 518(7538): 197-206. doi: 10.1038/nature14177